CA Stock MarketDetailed Quotes

MBX Microbix Biosystems Inc

Watchlist
  • 0.320
  • 0.0000.00%
15min DelayMarket Closed Nov 1 16:00 ET
43.75MMarket Cap8.65P/E (TTM)

Microbix Biosystems Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-34.15%1.4M
179.48%839.25K
287.56%1.34M
-131.59%-1.09M
-1,094.43%-1.46M
-21.34%2.13M
-218.21%-1.06M
-151.35%-713.87K
64.48%3.47M
-90.97%146.44K
Net income from continuing operations
132.08%246.75K
1,094.74%377.73K
288.98%2.46M
-102.21%-39.48K
530.37%2M
-220.46%-769.11K
-95.69%31.62K
-247.51%-1.3M
-44.68%1.79M
-159.58%-464.08K
Operating gains losses
---166.63K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
40.25%426.66K
33.64%404.15K
58.49%382.43K
11.65%1.16M
6.23%309.23K
15.27%304.22K
17.09%302.43K
8.16%241.29K
26.08%1.04M
28.28%291.1K
Asset impairment expenditure
----
----
----
---3.08M
----
----
----
----
--0
----
Remuneration paid in stock
-10.15%181.89K
2.89%190.9K
13.30%198.25K
13.18%735.32K
-6.16%172.36K
7.72%202.45K
23.33%185.54K
37.08%174.97K
71.95%649.69K
43.69%183.67K
Other non cashItems
16.29%110.77K
39.26%110.6K
41.60%106.12K
6.16%350.86K
39.63%101.24K
21.11%95.25K
-7.20%79.42K
-20.07%74.94K
-62.95%330.51K
-88.41%72.51K
Change In working capital
-73.72%604.06K
85.25%-244.14K
-2,014.60%-1.8M
35.36%-219.84K
-1,614.59%-957.71K
49.20%2.3M
-394.61%-1.65M
105.85%94.18K
89.43%-340.09K
145.93%63.23K
-Change in receivables
--394.84K
-107.64%-600.87K
61.00%313.01K
-197.35%-1.09M
----
----
-128.58%-289.38K
114.04%194.42K
148.17%1.12M
-3,782.97%-571.54K
-Change in inventory
---92.03K
98.31%-12.94K
51.08%-392.48K
46.76%-467.11K
----
----
-55.81%-766.78K
-81.18%-802.24K
-664.00%-877.41K
-96.74%13.54K
-Change in prepaid assets
--398.51K
-354.56%-277.77K
-27.52%-143.52K
-171.62%-139.27K
----
----
127.73%109.12K
3.48%-112.55K
81.35%-51.27K
552.25%950.01K
-Change in payables and accrued expense
--295.19K
138.49%70.5K
-182.05%-315.48K
215.85%251.14K
----
----
65.37%-183.15K
-1,625.52%-111.85K
-220.91%-216.77K
1,192.81%293.93K
-Change in other working capital
---392.45K
209.96%576.94K
-236.52%-1.26M
492.80%1.22M
----
----
-880.46%-524.67K
183.02%926.41K
54.88%-311.2K
-77.43%-622.72K
Cash from discontinued investing activities
Operating cash flow
-34.15%1.4M
179.48%839.25K
287.56%1.34M
-131.59%-1.09M
-1,094.42%-1.46M
-21.34%2.13M
-218.21%-1.06M
-151.35%-713.87K
64.48%3.47M
-90.97%146.44K
Investing cash flow
Cash flow from continuing investing activities
-366.10%-1M
-15.75%-637.91K
72.23%-36.7K
49.83%-1.02M
90.24%-117.85K
18.72%-215.11K
-37.65%-551.11K
13.78%-132.15K
-225.49%-2.03M
-1,535.96%-1.21M
Net PPE purchase and sale
-240.31%-732.05K
-15.75%-637.91K
72.23%-36.7K
49.83%-1.02M
90.24%-117.85K
18.72%-215.11K
-37.65%-551.11K
13.78%-132.15K
-62.99%-2.03M
-839.11%-1.21M
Net intangibles purchas and sale
---270.6K
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-366.10%-1M
-15.75%-637.91K
72.23%-36.7K
49.83%-1.02M
90.24%-117.85K
18.72%-215.11K
-37.65%-551.11K
13.78%-132.15K
-225.49%-2.03M
-1,535.96%-1.21M
Financing cash flow
Cash flow from continuing financing activities
-103.39%-465.14K
-112.30%-111.11K
41.92%-125.88K
-88.89%229.21K
-159.26%-228.62K
52.62%-228.69K
-25.52%903.25K
-122.90%-216.73K
-75.48%2.06M
-58.61%385.77K
Net issuance payments of debt
-312.18%-302.51K
-106.03%-73.33K
-153.76%-73.33K
189.67%1.24M
54.44%-40.19K
87.51%-73.39K
24.02%1.22M
108.09%136.39K
-1,749.00%-1.38M
-2,775.78%-88.23K
Net common stock issuance
2.06%-162.63K
1.26%-395.08K
85.43%-52.56K
---1.12M
---188.43K
---166.05K
---400.11K
---360.68K
--0
--0
Proceeds from stock option exercised by employees
--0
310.93%357.3K
--0
-96.94%105.26K
--0
-89.76%10.75K
-62.51%86.95K
-99.71%7.56K
56.99%3.44M
-49.65%474K
Cash from discontinued financing activities
Financing cash flow
-103.39%-465.14K
-112.30%-111.11K
41.92%-125.88K
-88.89%229.21K
-159.26%-228.62K
52.62%-228.69K
-25.52%903.25K
-122.90%-216.73K
-75.48%2.06M
-58.61%385.77K
Net cash flow
Beginning cash position
9.82%12.87M
2.88%12.78M
-13.95%11.61M
35.07%13.49M
-5.32%13.41M
-3.93%11.72M
18.39%12.43M
35.07%13.49M
10,677.25%9.99M
88.68%14.16M
Current changes in cash
-103.81%-64.31K
112.82%90.23K
210.69%1.18M
-153.73%-1.88M
-167.02%-1.8M
-14.00%1.69M
-141.26%-703.72K
-308.75%-1.06M
-64.61%3.5M
-127.22%-675.12K
End cash Position
-4.48%12.81M
9.82%12.87M
2.88%12.78M
-13.95%11.61M
-13.95%11.61M
-5.32%13.41M
-3.93%11.72M
18.39%12.43M
35.07%13.49M
35.07%13.49M
Free cash from
-79.08%400.84K
112.53%201.34K
253.93%1.3M
-246.63%-2.11M
-48.37%-1.57M
-21.62%1.92M
-426.05%-1.61M
-93.47%-846.02K
79.01%1.44M
-171.05%-1.06M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -34.15%1.4M179.48%839.25K287.56%1.34M-131.59%-1.09M-1,094.43%-1.46M-21.34%2.13M-218.21%-1.06M-151.35%-713.87K64.48%3.47M-90.97%146.44K
Net income from continuing operations 132.08%246.75K1,094.74%377.73K288.98%2.46M-102.21%-39.48K530.37%2M-220.46%-769.11K-95.69%31.62K-247.51%-1.3M-44.68%1.79M-159.58%-464.08K
Operating gains losses ---166.63K------------------------------------
Depreciation and amortization 40.25%426.66K33.64%404.15K58.49%382.43K11.65%1.16M6.23%309.23K15.27%304.22K17.09%302.43K8.16%241.29K26.08%1.04M28.28%291.1K
Asset impairment expenditure ---------------3.08M------------------0----
Remuneration paid in stock -10.15%181.89K2.89%190.9K13.30%198.25K13.18%735.32K-6.16%172.36K7.72%202.45K23.33%185.54K37.08%174.97K71.95%649.69K43.69%183.67K
Other non cashItems 16.29%110.77K39.26%110.6K41.60%106.12K6.16%350.86K39.63%101.24K21.11%95.25K-7.20%79.42K-20.07%74.94K-62.95%330.51K-88.41%72.51K
Change In working capital -73.72%604.06K85.25%-244.14K-2,014.60%-1.8M35.36%-219.84K-1,614.59%-957.71K49.20%2.3M-394.61%-1.65M105.85%94.18K89.43%-340.09K145.93%63.23K
-Change in receivables --394.84K-107.64%-600.87K61.00%313.01K-197.35%-1.09M---------128.58%-289.38K114.04%194.42K148.17%1.12M-3,782.97%-571.54K
-Change in inventory ---92.03K98.31%-12.94K51.08%-392.48K46.76%-467.11K---------55.81%-766.78K-81.18%-802.24K-664.00%-877.41K-96.74%13.54K
-Change in prepaid assets --398.51K-354.56%-277.77K-27.52%-143.52K-171.62%-139.27K--------127.73%109.12K3.48%-112.55K81.35%-51.27K552.25%950.01K
-Change in payables and accrued expense --295.19K138.49%70.5K-182.05%-315.48K215.85%251.14K--------65.37%-183.15K-1,625.52%-111.85K-220.91%-216.77K1,192.81%293.93K
-Change in other working capital ---392.45K209.96%576.94K-236.52%-1.26M492.80%1.22M---------880.46%-524.67K183.02%926.41K54.88%-311.2K-77.43%-622.72K
Cash from discontinued investing activities
Operating cash flow -34.15%1.4M179.48%839.25K287.56%1.34M-131.59%-1.09M-1,094.42%-1.46M-21.34%2.13M-218.21%-1.06M-151.35%-713.87K64.48%3.47M-90.97%146.44K
Investing cash flow
Cash flow from continuing investing activities -366.10%-1M-15.75%-637.91K72.23%-36.7K49.83%-1.02M90.24%-117.85K18.72%-215.11K-37.65%-551.11K13.78%-132.15K-225.49%-2.03M-1,535.96%-1.21M
Net PPE purchase and sale -240.31%-732.05K-15.75%-637.91K72.23%-36.7K49.83%-1.02M90.24%-117.85K18.72%-215.11K-37.65%-551.11K13.78%-132.15K-62.99%-2.03M-839.11%-1.21M
Net intangibles purchas and sale ---270.6K------------------0----------------
Cash from discontinued investing activities
Investing cash flow -366.10%-1M-15.75%-637.91K72.23%-36.7K49.83%-1.02M90.24%-117.85K18.72%-215.11K-37.65%-551.11K13.78%-132.15K-225.49%-2.03M-1,535.96%-1.21M
Financing cash flow
Cash flow from continuing financing activities -103.39%-465.14K-112.30%-111.11K41.92%-125.88K-88.89%229.21K-159.26%-228.62K52.62%-228.69K-25.52%903.25K-122.90%-216.73K-75.48%2.06M-58.61%385.77K
Net issuance payments of debt -312.18%-302.51K-106.03%-73.33K-153.76%-73.33K189.67%1.24M54.44%-40.19K87.51%-73.39K24.02%1.22M108.09%136.39K-1,749.00%-1.38M-2,775.78%-88.23K
Net common stock issuance 2.06%-162.63K1.26%-395.08K85.43%-52.56K---1.12M---188.43K---166.05K---400.11K---360.68K--0--0
Proceeds from stock option exercised by employees --0310.93%357.3K--0-96.94%105.26K--0-89.76%10.75K-62.51%86.95K-99.71%7.56K56.99%3.44M-49.65%474K
Cash from discontinued financing activities
Financing cash flow -103.39%-465.14K-112.30%-111.11K41.92%-125.88K-88.89%229.21K-159.26%-228.62K52.62%-228.69K-25.52%903.25K-122.90%-216.73K-75.48%2.06M-58.61%385.77K
Net cash flow
Beginning cash position 9.82%12.87M2.88%12.78M-13.95%11.61M35.07%13.49M-5.32%13.41M-3.93%11.72M18.39%12.43M35.07%13.49M10,677.25%9.99M88.68%14.16M
Current changes in cash -103.81%-64.31K112.82%90.23K210.69%1.18M-153.73%-1.88M-167.02%-1.8M-14.00%1.69M-141.26%-703.72K-308.75%-1.06M-64.61%3.5M-127.22%-675.12K
End cash Position -4.48%12.81M9.82%12.87M2.88%12.78M-13.95%11.61M-13.95%11.61M-5.32%13.41M-3.93%11.72M18.39%12.43M35.07%13.49M35.07%13.49M
Free cash from -79.08%400.84K112.53%201.34K253.93%1.3M-246.63%-2.11M-48.37%-1.57M-21.62%1.92M-426.05%-1.61M-93.47%-846.02K79.01%1.44M-171.05%-1.06M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data